This is a preview of subscription content, log in via an institution to check access.
Reference
Seymour EK, et al. The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States. Cancer : 29 Oct 2020. Available from: URL: http://doi.org/10.1002/cncr.33267
Rights and permissions
About this article
Cite this article
Tyrosine kinase inhibitors in CML: better outcomes, lower hospital cost. PharmacoEcon Outcomes News 866, 31 (2020). https://doi.org/10.1007/s40274-020-7291-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7291-6